{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:17:09Z","timestamp":1792441029593,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012479","name":"General Research Fund of Shanghai Normal University","doi-asserted-by":"publisher","award":["17111524"],"award-info":[{"award-number":["17111524"]}],"id":[{"id":"10.13039\/501100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032443","name":"Hong Kong Jockey Club","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014820","name":"The University of Hong Kong Li Ka Shing Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eclinm.2026.104017","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:03Z","timestamp":1781632443000},"page":"104017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy and effectiveness of long-acting monoclonal antibodies and vaccines against RSV: a systematic review and meta-analysis of studies from 2018 to 2025"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6407-172X","authenticated-orcid":false,"given":"Jiayi","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan F.N.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-388X","authenticated-orcid":false,"given":"Kathy","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10340","key":"10.1016\/j.eclinm.2026.104017_bib1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13031","article-title":"Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis","volume":"17","author":"Savic","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104017_bib3","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ajt.2023.09.003","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on immunization practices\u2014United States, 2023","volume":"23","author":"Melgar","year":"2023","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.25285","article-title":"Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and\/or congestive heart failure","volume":"91","author":"Falsey","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2026.104017_bib5","author":"Weiwei"},{"issue":"3 Pt 1","key":"10.1016\/j.eclinm.2026.104017_bib6","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.eclinm.2026.104017_bib7","series-title":"SYNAGIS (palivizumab) for Intramuscular Administration MedImmune","year":"1999"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib8","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104017_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-Dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104017_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.eclinm.2026.104017_bib11","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104017_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104017_bib13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.eclinm.2026.104017_bib14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-Based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104017_bib15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F Vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104017_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","article-title":"Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial","volume":"145","author":"Sim\u00f5es","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104017_bib18","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"19","key":"10.1016\/j.eclinm.2026.104017_bib21","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. Special communication","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104017_bib22","series-title":"R: a language and environment for statistical computing","year":"2025"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/ijb-2022-0070","article-title":"Heterogeneity in meta-analysis: a comprehensive overview","volume":"20","author":"Stogiannis","year":"2024","journal-title":"Int J Biostat"},{"key":"10.1016\/j.eclinm.2026.104017_bib24","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Chapter 13: assessing risk of bias due to missing results","author":"Page","year":"2022"},{"issue":"48","key":"10.1016\/j.eclinm.2026.104017_bib26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.15585\/mmwr.mm7348a4","article-title":"Rollout of nirsevimab to protect infants and young children during the respiratory syncytial virus season \u2014 new York City, 2023\u20132024","volume":"73","author":"Askari","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104017_bib27","article-title":"Understanding real-world effectiveness of nirsevimab and the characteristics of breakthrough RSV infections: a study protocol of individual-participant-level data meta-analysis (the GEMINI study)","volume":"13","author":"Ren","year":"2026","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104017_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the test-negative study design for assessment of Influenza vaccine effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104017_bib29","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for prevention of RSV disease in healthy infants","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"issue":"6543","key":"10.1016\/j.eclinm.2026.104017_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.abf9571","article-title":"Preventing respiratory syncytial virus (RSV) disease in children","volume":"372","author":"Karron","year":"2021","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104017_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV prefusion F protein-based maternal vaccine - preterm birth and other outcomes","volume":"390","author":"Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104017_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine","volume":"145","author":"Madhi","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"41","key":"10.1016\/j.eclinm.2026.104017_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eclinm.2026.104017_bib35","series-title":"Immunization to protect infants against Respiratory Syncytial Virus (RSV) disease: WHO position paper. Weekly Epidemiological Record","year":"2024"},{"key":"10.1016\/j.eclinm.2026.104017_bib36","series-title":"Estrat\u00e9gia de vacina\u00e7\u00e3o contra o v\u00edrus sincicial respirat\u00f3rio em gestantes (Minist\u00e9rio da Sa\u00fade)","first-page":"39","year":"2026"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104017_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(24)00796-5","article-title":"Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study","volume":"25","author":"Bajema","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104017_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2509810","article-title":"RSV prefusion F vaccine for prevention of hospitalization in older adults","volume":"394","author":"Lassen","year":"2026","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104017_bib39","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jama.2025.15896","article-title":"RSV vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons","volume":"334","author":"Surie","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104017_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial Virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:28:05Z","timestamp":1791232085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702600266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S258953702600266X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104017","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and effectiveness of long-acting monoclonal antibodies and vaccines against RSV: a systematic review and meta-analysis of studies from 2018 to 2025","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104017"}}